Medical Monopoly: Intellectual Property Rights And The Origins Of The Modern Pharmaceutical Industry by Joseph M. Gabriel

Medical Monopoly: Intellectual Property Rights And The Origins Of The Modern Pharmaceutical Industry

byJoseph M. Gabriel

Hardcover | October 24, 2014

not yet rated|write a review

Pricing and Purchase Info


Earn 228 plum® points

In stock online

Ships free on orders over $25

Not available in stores


During much of the nineteenth century, physicians and pharmacists alike considered medical patenting and the use of trademarks by drug manufacturers unethical forms of monopoly; physicians who prescribed patented drugs could be, and were, ostracized from the medical community. In the decades following the Civil War, however, complex changes in patent and trademark law intersected with the changing sensibilities of both physicians and pharmacists to make intellectual property rights in drug manufacturing scientifically and ethically legitimate. By World War I, patented and trademarked drugs had become essential to the practice of good medicine, aiding in the rise of the American pharmaceutical industry and forever altering the course of medicine.
Drawing on a wealth of previously unused archival material, Medical Monopoly combines legal, medical, and business history to offer a sweeping new interpretation of the origins of the complex and often troubling relationship between the pharmaceutical industry and medical practice today. Joseph M. Gabriel provides the first detailed history of patent and trademark law as it relates to the nineteenth-century pharmaceutical industry as well as a unique interpretation of medical ethics, therapeutic reform, and the efforts to regulate the market in pharmaceuticals before World War I. His book will be of interest not only to historians of medicine and science and intellectual property scholars but also to anyone following contemporary debates about the pharmaceutical industry, the patenting of scientific discoveries, and the role of advertising in the marketplace.

About The Author

Joseph M. Gabriel is the George Urdang Associate Professor of the History of Pharmacy at the University of Wisconsin.
Sans-peur le corsaire
Sans-peur le corsaire

by Guillaume Joseph Gabriel de La Landelle


Available for download

Not available in stores

Le Salon de 1834
Le Salon de 1834

by Gabriel-Joseph-Hippolyte Laviron


Available for download

Not available in stores

Shop this author

Details & Specs

Title:Medical Monopoly: Intellectual Property Rights And The Origins Of The Modern Pharmaceutical IndustryFormat:HardcoverDimensions:328 pages, 9 × 6 × 1.2 inPublished:October 24, 2014Publisher:University Of Chicago PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:022610818X

ISBN - 13:9780226108186

Look for similar items by category:

Customer Reviews of Medical Monopoly: Intellectual Property Rights And The Origins Of The Modern Pharmaceutical Industry


Extra Content

Table of Contents

A Note about Terms

1 Medical Science and Property Rights in the Early Republic
2 Monopoly and Ethics in the Antebellum Years
3 In the Shadow of War
4 Therapeutic Reform and the Reinterpretation of Monopoly
5 The Ambiguities of Abundance
6 The Embrace of Intellectual Property
Conclusion: The Promise of Reform

Archival Collections Consulted


Editorial Reviews

“Medical Monopoly is a fascinating book about the history of intellectual property (IP) rights in pharmaceuticals. Gabriel traces the role that patents and trademarks played in the development of the pharmaceutical industry, explores the question of whether IP rights promoted research and development, and identifies the changing attitudes of physicians and scientists to the propriety of patenting drugs. The book reaches a number of conclusions that are surprising to the contemporary student of both IP and pharmaceuticals, and Gabriel does a nice job of marshaling the massive amount of evidence he uncovered into a chronological narrative. This important work will be of interest to historians of patents and trademarks; to historians of medicine, science, and technology; and to scholars of contemporary IP and science policy.”